C2 BIOENGINEERING ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 18.0% 18.9%  
Credit score (0-100)  0 0 0 10 8  
Credit rating  N/A N/A N/A B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12

Net sales  0 0 0 24 26  
Gross profit  0.0 0.0 0.0 24.1 25.6  
EBITDA  0.0 0.0 0.0 -106 -12.3  
EBIT  0.0 0.0 0.0 -106 -12.3  
Pre-tax profit (PTP)  0.0 0.0 0.0 -106.5 -12.3  
Net earnings  0.0 0.0 0.0 -106.5 -12.3  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -107 -12.3  

 
See the entire income statement

Balance sheet (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 207 195  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 214 204  

Net Debt  0.0 0.0 0.0 -193 -177  
 
See the entire balance sheet

Volume 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12

Net sales  0 0 0 24 26  
Net sales growth  0.0% 0.0% 0.0% 0.0% 6.4%  
Gross profit  0.0 0.0 0.0 24.1 25.6  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 6.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -91.0 -4.6  
Balance sheet total (assets)  0 0 0 214 204  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -4.7%  
Added value  0.0 0.0 0.0 -15.5 -7.7  
Added value %  0.0% 0.0% 0.0% -64.5% -30.1%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 1.0  
EBIT trend  0.0 0.0 0.0 -1.0 -2.0  

Profitability 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
EBITDA %  0.0% 0.0% 0.0% -442.4% -48.0%  
EBIT %  0.0% 0.0% 0.0% -442.4% -48.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -442.4% -48.0%  
Net Earnings %  0.0% 0.0% 0.0% -442.5% -48.1%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% -442.5% -48.1%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% -442.5% -48.1%  
ROA %  0.0% 0.0% 0.0% -49.8% -5.9%  
ROI %  0.0% 0.0% 0.0% -51.5% -6.1%  
ROE %  0.0% 0.0% 0.0% -51.5% -6.1%  

Solidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Equity ratio %  0.0% 0.0% 0.0% 96.8% 95.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 28.6% 35.6%  
Relative net indebtedness %  0.0% 0.0% 0.0% -773.7% -654.1%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 181.4% 1,436.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Quick Ratio  0.0 0.0 0.0 31.0 22.4  
Current Ratio  0.0 0.0 0.0 31.0 22.4  
Cash and cash equivalent  0.0 0.0 0.0 193.1 176.7  

Capital use efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Trade debtors turnover (days)  0.0 0.0 0.0 312.8 384.9  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 888.0% 795.1%  
Net working capital  0.0 0.0 0.0 206.9 194.6  
Net working capital %  0.0% 0.0% 0.0% 859.4% 759.5%  

Employee efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0